These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1750062

  • 21. The effect of antilymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs.
    Hartner WC, Markees TG, De Fazio SR, Khouri W, Maki T, Monaco AP, Gozzo JJ.
    Transplantation; 1991 Nov; 52(5):784-9. PubMed ID: 1835194
    [Abstract] [Full Text] [Related]

  • 22. Prophylaxis of heart transplant rejection with either antithymocyte globulin-, Minnesota antilymphocyte globulin-, or an OKT3-based protocol.
    Ladowski JS, Dillon T, Schatzlein MH, Peterson AC, Deschner WP, Beatty L, Sullivan M, Scheeringa RH, Clark WR.
    J Cardiovasc Surg (Torino); 1993 Apr; 34(2):135-40. PubMed ID: 8320247
    [Abstract] [Full Text] [Related]

  • 23. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L, Ding T, Wang XX, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681
    [Abstract] [Full Text] [Related]

  • 24. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 25. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun 15; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 26. Early graft function.
    Toyotome A, Terasaki PI, Salvatierra O, Starzl T, Hakala T, Kahan B, Diethelm A, Najarian J, Wolf J, Butt K.
    Clin Transpl; 1987 Jun 15; ():435-52. PubMed ID: 3154444
    [Abstract] [Full Text] [Related]

  • 27. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL, Venkatachalam KK, Oh HK, Dienst S, Levin NW.
    Transplantation; 1985 Dec 15; 40(6):601-4. PubMed ID: 3907029
    [Abstract] [Full Text] [Related]

  • 28. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb 15; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 29. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants.
    Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P.
    Transplantation; 1992 Feb 15; 53(2):323-8. PubMed ID: 1738926
    [Abstract] [Full Text] [Related]

  • 30. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Feb 15; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 31. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
    Ross DJ, Jordan SC, Nathan SD, Kass RM, Koerner SK.
    Chest; 1996 Apr 15; 109(4):870-3. PubMed ID: 8635362
    [Abstract] [Full Text] [Related]

  • 32. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE.
    Ann Surg; 1985 Feb 15; 201(2):142-57. PubMed ID: 3882063
    [Abstract] [Full Text] [Related]

  • 33. Safety of low-dose cyclosporine therapy before transplantation in kidney allograft recipients.
    Khosroshahi HT, Badrogli N, Jahannavard N, Oskuii R, Bahluli A, Azar SA, Ardalan M.
    Transplant Proc; 2009 Sep 15; 41(7):2757-60. PubMed ID: 19765427
    [Abstract] [Full Text] [Related]

  • 34. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
    Amada N, Okazaki H, Sato T, Ohashi Y, Kikuchi H.
    Transplant Proc; 2005 Mar 15; 37(2):927-9. PubMed ID: 15848577
    [Abstract] [Full Text] [Related]

  • 35. Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients.
    Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL, Sutherland DE, Najarian JS.
    Transplantation; 1992 Jul 15; 54(1):50-6. PubMed ID: 1631944
    [Abstract] [Full Text] [Related]

  • 36. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ, Benvenisty AI, Cianci J, Hardy MA.
    Am J Kidney Dis; 1989 Nov 15; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [Abstract] [Full Text] [Related]

  • 37. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec 15; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 38. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC, Fisher RA, Dattilo JB, Cohen DS, Tawes JW, Dattilo MP, Babcock GF, Frede SE, Wakely PE, Posner MP.
    Transplantation; 1997 Jan 27; 63(2):310-4. PubMed ID: 9020336
    [Abstract] [Full Text] [Related]

  • 39. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine.
    Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC.
    Transplantation; 1988 Aug 27; 46(2):223-8. PubMed ID: 3043779
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for second renal allografts immunosuppressed with cyclosporine.
    Almond PS, Matas AJ, Gillingham K, Troppmann C, Payne W, Dunn D, Sutherland D, Najarian JS.
    Transplantation; 1991 Aug 27; 52(2):253-8. PubMed ID: 1871798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.